Langerhans cells require signals from both tumour necrosis factor alpha and interleukin 1 beta for migration.
Cumberbatch
M
M
Zeneca Central Toxicology Laboratory, Macclesfield Cheshire, United Kingdom.
Dearman
R J
RJ
Kimber
I
I
D000276:Adjuvants, Immunologic / Q000494:pharmacology; D000818:Animals; D000906:Antibodies / Q000494:pharmacology; D002465:Cell Movement / Q000187:drug effects; D003713:Dendritic Cells / Q000187:drug effects / Q000276:immunology / Q000502:physiology; D007375:Interleukin-1 / Q000037:antagonists & inhibitors / Q000502:physiology*; D007801:Langerhans Cells / Q000187:drug effects / Q000276:immunology* / Q000502:physiology*; D008198:Lymph Nodes / Q000166:cytology / Q000187:drug effects; D051379:Mice; D008807:Mice, Inbred BALB C; D009500:Neutralization Tests; D010081:Oxazolone / Q000494:pharmacology; D015398:Signal Transduction; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors / Q000502:physiology*
D000276:Adjuvants, Immunologic; D000906:Antibodies; D007375:Interleukin-1; D014409:Tumor Necrosis Factor-alpha; D010081:Oxazolone